Evidence map›Paper›PMID 33027362›Full record

Trial reportActa cirurgica brasileira2020

Antibiotic prophylaxis in breast cancer surgery. A randomized controlled trial.

Rubens Murilo de Athayde Prudencio, Fabíola Soares Moreira Campos, Ana Beatriz Alkmim Teixeira Loyola, Ivanildo Archangelo Junior, Neil Ferreira Novo, Lydia Masako Ferreira, Daniela Francescato Veiga

Open access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Acta cirurgica brasileira, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
1.2field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 10 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 3 countries.

Rubens Murilo de Athayde PrudencioMaster, Professional Master's Program in Applied Health Sciences, Universidade do Vale do Sapucaí (UNIVÁS), Pouso Alegre-MG, and Breast Cancer Unit, Hospital São Cristóvão, Sao Paulo-SP, Brazil. Conception, design, intellectual and scientific content of the study; acquisition, interpretation and analysis of data; manuscript writing; final approval.ORCID http://orcid.org/0000-0002-6600-3859
Fabíola Soares Moreira CamposMaster, Professional Master's Program in Applied Health Sciences, and Hospital das Clínicas Samuel Libânio, UNIVÁS, Pouso Alegre-MG, Brazil. Conception, design, intellectual and scientific content of the study; acquisition, interpretation and analysis of data; manuscript writing; final approval.ORCID http://orcid.org/0000-0002-0536-8918
Ana Beatriz Alkmim Teixeira LoyolaPhD, Associate Professor, Professional Master's Program in Applied Health Sciences, UNIVÁS, Pouso Alegre-MG, Brazil. Conception, design, intellectual and scientific content of the study; interpretation and analysis of data; manuscript writing; critical revision; final approval.ORCID http://orcid.org/0000-0002-9089-7012
Ivanildo Archangelo JuniorMD, Department of Breast Surgery, UNIVÁS, Pouso Alegre-MG, Brazil. Conception, design, intellectual and scientific content of the study; acquisition of data; final approval.ORCID http://orcid.org/0000-0003-0338-5236
Neil Ferreira NovoPhD, Full Professor, Department of Biostatistics, UNIVÁS, Pouso Alegre-MG, Brazil. Interpretation of data, statistical analysis, critical revision, final approval.ORCID http://orcid.org/0000-0001-7903-8156
Lydia Masako FerreiraPhD, Chairwoman, Head, Postgraduate Program in Translational Surgery, Division of Plastic Surgery, Universidade Federal de São Paulo (UNIFESP), Sao Paulo-SP, Brazil. Critical revision, final approval.ORCID http://orcid.org/0000-0003-4587-509X
Daniela Francescato VeigaPhD, Associate Professor, Professional Master's Program in Applied Health Sciences, UNIVÁS, Pouso Alegre-MG, and Postgraduate Program in Translational Surgery, UNIFESP, Sao Paulo-SP, Brazil. Conception, design, intellectual and scientific content of the study; interpretation and analysis of data; manuscript writing; critical revision; final approval.ORCID http://orcid.org/0000-0002-8713-2940
Universidade do Vale do Sapucaí · BRFundação de Apoio à Universidade Federal de São Paulo · BRUniversidade Federal de São Paulo · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTo assess the effect of antibiotic prophylaxis on surgical site infection (SSI) rates in women undergoing breast cancer surgery in two tertiary hospitals in Brazil.

methodsThis was a randomized, double-blind, placebo-controlled, parallel-group clinical trial. A total of 124 women without independent risk factors for SSI were randomly assigned to receive either cefazolin (antibiotic group, n = 62) or placebo (control group, n = 62) as preoperative prophylaxis. After surgery, all surgical wounds were examined once a week, for four weeks, according to the Centers for Disease Control and Prevention definitions and classifications for SSI.

resultsBaseline characteristics were homogeneous between the two groups. Only one patient in the antibiotic group developed SSI, which was classified as superficial incisional. The overall SSI rate was low, with no significant difference between groups.

conclusionAntibiotic prophylaxis had no significant effect on reducing SSI rates in women without independent risk factors for SSI undergoing breast cancer surgery.

Indexed as

Antibiotic ProphylaxisBreast NeoplasmsSurgical Wound InfectionBrazilDouble-Blind MethodFemaleHumansMastectomyUnited States

Identifiers

PMID33027362
PMCPMC7531055
OpenAlexW3091426762

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.